Burrowing Behavior as Robust Parameter for Early Humane Endpoint Determination in Murine Models for Pancreatic Cancer
Authors:
- Jakob BrandstetterJBJakob Brandstetter
- Lisa HoffmannLHLisa Hoffmann
- Ingo KoopmannIKIngo Koopmann
- Tim SchreiberTSTim Schreiber
- Benjamin SchulzBSBenjamin Schulz
- Stephan Patrick RosshartSRStephan Patrick Rosshart
- Dietmar ZechnerDZDietmar Zechner
- Brigitte VollmarBVBrigitte Vollmar
- Simone KumstelSKSimone Kumstel
Open Access
Abstract
Due to late-stage diagnoses and limited treatment options, pancreatic cancer is predicted to be the second leading cause of cancer deaths by 2030. Many different murine models were developed over the past decades to test new therapies for this tumor entity. The laws and regulations demand the continuous refinement of animal experiments in order to improve animal welfare sustainably. A key aspect here is the definition of early humane endpoint criteria to avoid severe and lasting suffering of the animals through timely euthanasia. The present study analyzed the welfare of mice in different pancreatic cancer models, various mouse strains, and under different therapeutic interventions in preclinical testing. Their welfare was monitored before any intervention, during tumor progression, and on the days before the individual humane endpoint for each mouse by assessing body weight change, distress score, perianal temperature, burrowing behavior, nesting activity, and mouse grimace scale. The data was retrospectively analyzed via receiver operating characteristic curve analysis to quantify the predictability of each parameter for humane endpoint determination. Burrowing behavior proved to be a robust predictor of the humane endpoint two days in advance under various conditions, including diverse pancreatic cancer models and different therapeutic approaches.Keywords
Funding Information
- German Research Foundation (KU36301-1, 446316360, 256073931, 491676693)
- German Research Foundation, Emmy Noether Programm RO 6247/1-1 (KU36301-1, 446316360, 256073931, 491676693)
- DFG SFB1160 IMPATH (KU36301-1, 446316360, 256073931, 491676693)
- TRR 359 PILOT (KU36301-1, 446316360, 256073931, 491676693)
This publication has 61 references indexed in Scilit:
- Humane Endpoint: Example from a Murine Model of Disseminated SporotrichosisCurrent Microbiology, 2024
- Pancreatic cancer: Advances and challengesCell, 2023
- In vivo models of pancreatic ductal adenocarcinoma2023
- Modeling pancreatic cancer in mice for experimental therapeuticsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2021
- Orofacial neuropathic pain reduces spontaneous burrowing behavior in ratsPhysiology & Behavior, 2018
- Cell cultures in drug discovery and development: The need of reliable in vitro-in vivo extrapolation for pharmacodynamics and pharmacokinetics assessmentJournal of Pharmaceutical and Biomedical Analysis, 2018
- Wild Mouse Gut Microbiota Promotes Host Fitness and Improves Disease ResistanceCell, 2017
- The Strength of Association Between Surrogate End Points and Survival in OncologyJAMA Internal Medicine, 2015
- Progression-free survival as an end-point in solid tumours – Perspectives from clinical trials and clinical practiceEuropean Journal of Cancer, 2014
- Individual housing of mice — Impact on behaviour and stress responsesPhysiology & Behavior, 2009